Details of the Drug

General Information of Drug (ID: DM715KM)

• Drug Name: Luspatercept

Indication

Disease Entry	ICD 11	Status	REF
Anaemia	3A90	Approved	[1]
Beta thalassemia	3A50.2	Phase 3	[2]
Myelodysplastic syndrome	2A37	Phase 3	[2]

• ATC Code:
  B03XA06: Luspatercept
  B03XA: Other antianemic preparations
  B03X: OTHER ANTIANEMIC PREPARATIONS
  B03: ANTIANEMIC PREPARATIONS
  B: BLOOD AND BLOOD FORMING ORGANS
• Cross-matching ID:
  UNII: AQK7UBA1LS
  DrugBank ID: DB12281
  TTD ID: D0S0WR
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)